STAT3 gain-of-function is not responsible for low total IgE levels in patients with autoimmune chronic spontaneous urticaria

BackgroundThe pathogenesis of chronic spontaneous urticaria (CSU) has not been clarified entirely. Type IIb autoimmune chronic spontaneous urticaria (CSUaiTIIb) is a distinct subtype of CSU that is often difficult to treat and is connected to low levels of total IgE. Previous findings indicate that...

Full description

Bibliographic Details
Main Authors: Merle Sauer, Jörg Scheffel, Stefan Frischbutter, Niklas Mahnke, Marcus Maurer, Thomas Burmeister, Karoline Krause, Martin Metz
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.902652/full
_version_ 1811218462198988800
author Merle Sauer
Jörg Scheffel
Jörg Scheffel
Stefan Frischbutter
Stefan Frischbutter
Niklas Mahnke
Niklas Mahnke
Marcus Maurer
Marcus Maurer
Thomas Burmeister
Karoline Krause
Karoline Krause
Martin Metz
Martin Metz
author_facet Merle Sauer
Jörg Scheffel
Jörg Scheffel
Stefan Frischbutter
Stefan Frischbutter
Niklas Mahnke
Niklas Mahnke
Marcus Maurer
Marcus Maurer
Thomas Burmeister
Karoline Krause
Karoline Krause
Martin Metz
Martin Metz
author_sort Merle Sauer
collection DOAJ
description BackgroundThe pathogenesis of chronic spontaneous urticaria (CSU) has not been clarified entirely. Type IIb autoimmune chronic spontaneous urticaria (CSUaiTIIb) is a distinct subtype of CSU that is often difficult to treat and is connected to low levels of total IgE. Previous findings indicate that an enhanced signal transducer and activator of transcription 3 (STAT3) may be responsible for reduced IgE serum levels.ObjectiveOur aim was to investigate a possible underlying gain-of-function mutation or activating polymorphism in STAT3 that could be responsible for the low levels of IgE in patients with CSUaiTIIb.MethodsWe included 10 patients with CSUaiTIIb and low levels of IgE and sequenced selected single nucleotide polymorphisms (SNP) in STAT3 associated with common autoimmune diseases. Exon sequencing was performed for the most relevant exons of STAT3. To test for a gain-of-function of STAT3, we performed a phospho-specific flow cytometry analysis of STAT3 in peripheral blood mononuclear cells before and after stimulation with interleukin-6.ResultsNo differences were found in the prevalence of the tested SNPs between our patients and a control population. Moreover, we could not find any mutations or variants on the tested exons of STAT3. The function of STAT3 was also not altered in our patients.ConclusionIn total, we could not find any evidence for our hypothesis that low IgE in patients with CSUaiTIIb is linked to mutations in STAT3 or altered activity of STAT3. Thus, it remains to be discovered what causes the low serum levels of IgE in patients with CSUaiTIIb.
first_indexed 2024-04-12T07:10:21Z
format Article
id doaj.art-38ff875985474b7d9f682856efcb4bec
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-12T07:10:21Z
publishDate 2022-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-38ff875985474b7d9f682856efcb4bec2022-12-22T03:42:39ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-07-011310.3389/fimmu.2022.902652902652STAT3 gain-of-function is not responsible for low total IgE levels in patients with autoimmune chronic spontaneous urticariaMerle Sauer0Jörg Scheffel1Jörg Scheffel2Stefan Frischbutter3Stefan Frischbutter4Niklas Mahnke5Niklas Mahnke6Marcus Maurer7Marcus Maurer8Thomas Burmeister9Karoline Krause10Karoline Krause11Martin Metz12Martin Metz13Institute of Allergology, Charité - Universitätsmedizin Berlin, Berlin, GermanyInstitute of Allergology, Charité - Universitätsmedizin Berlin, Berlin, GermanyFraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Allergology and Immunology, Berlin, GermanyInstitute of Allergology, Charité - Universitätsmedizin Berlin, Berlin, GermanyFraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Allergology and Immunology, Berlin, GermanyInstitute of Allergology, Charité - Universitätsmedizin Berlin, Berlin, GermanyFraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Allergology and Immunology, Berlin, GermanyInstitute of Allergology, Charité - Universitätsmedizin Berlin, Berlin, GermanyFraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Allergology and Immunology, Berlin, GermanyDepartment of Hematology, Oncology and Tumor Immunology, Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Berlin, GermanyInstitute of Allergology, Charité - Universitätsmedizin Berlin, Berlin, GermanyFraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Allergology and Immunology, Berlin, GermanyInstitute of Allergology, Charité - Universitätsmedizin Berlin, Berlin, GermanyFraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Allergology and Immunology, Berlin, GermanyBackgroundThe pathogenesis of chronic spontaneous urticaria (CSU) has not been clarified entirely. Type IIb autoimmune chronic spontaneous urticaria (CSUaiTIIb) is a distinct subtype of CSU that is often difficult to treat and is connected to low levels of total IgE. Previous findings indicate that an enhanced signal transducer and activator of transcription 3 (STAT3) may be responsible for reduced IgE serum levels.ObjectiveOur aim was to investigate a possible underlying gain-of-function mutation or activating polymorphism in STAT3 that could be responsible for the low levels of IgE in patients with CSUaiTIIb.MethodsWe included 10 patients with CSUaiTIIb and low levels of IgE and sequenced selected single nucleotide polymorphisms (SNP) in STAT3 associated with common autoimmune diseases. Exon sequencing was performed for the most relevant exons of STAT3. To test for a gain-of-function of STAT3, we performed a phospho-specific flow cytometry analysis of STAT3 in peripheral blood mononuclear cells before and after stimulation with interleukin-6.ResultsNo differences were found in the prevalence of the tested SNPs between our patients and a control population. Moreover, we could not find any mutations or variants on the tested exons of STAT3. The function of STAT3 was also not altered in our patients.ConclusionIn total, we could not find any evidence for our hypothesis that low IgE in patients with CSUaiTIIb is linked to mutations in STAT3 or altered activity of STAT3. Thus, it remains to be discovered what causes the low serum levels of IgE in patients with CSUaiTIIb.https://www.frontiersin.org/articles/10.3389/fimmu.2022.902652/fullautoimmune diseaseautoreactivitybasophil activation testchronic spontaneous urticariagain-of-function mutationimmunoglobulin E
spellingShingle Merle Sauer
Jörg Scheffel
Jörg Scheffel
Stefan Frischbutter
Stefan Frischbutter
Niklas Mahnke
Niklas Mahnke
Marcus Maurer
Marcus Maurer
Thomas Burmeister
Karoline Krause
Karoline Krause
Martin Metz
Martin Metz
STAT3 gain-of-function is not responsible for low total IgE levels in patients with autoimmune chronic spontaneous urticaria
Frontiers in Immunology
autoimmune disease
autoreactivity
basophil activation test
chronic spontaneous urticaria
gain-of-function mutation
immunoglobulin E
title STAT3 gain-of-function is not responsible for low total IgE levels in patients with autoimmune chronic spontaneous urticaria
title_full STAT3 gain-of-function is not responsible for low total IgE levels in patients with autoimmune chronic spontaneous urticaria
title_fullStr STAT3 gain-of-function is not responsible for low total IgE levels in patients with autoimmune chronic spontaneous urticaria
title_full_unstemmed STAT3 gain-of-function is not responsible for low total IgE levels in patients with autoimmune chronic spontaneous urticaria
title_short STAT3 gain-of-function is not responsible for low total IgE levels in patients with autoimmune chronic spontaneous urticaria
title_sort stat3 gain of function is not responsible for low total ige levels in patients with autoimmune chronic spontaneous urticaria
topic autoimmune disease
autoreactivity
basophil activation test
chronic spontaneous urticaria
gain-of-function mutation
immunoglobulin E
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.902652/full
work_keys_str_mv AT merlesauer stat3gainoffunctionisnotresponsibleforlowtotaligelevelsinpatientswithautoimmunechronicspontaneousurticaria
AT jorgscheffel stat3gainoffunctionisnotresponsibleforlowtotaligelevelsinpatientswithautoimmunechronicspontaneousurticaria
AT jorgscheffel stat3gainoffunctionisnotresponsibleforlowtotaligelevelsinpatientswithautoimmunechronicspontaneousurticaria
AT stefanfrischbutter stat3gainoffunctionisnotresponsibleforlowtotaligelevelsinpatientswithautoimmunechronicspontaneousurticaria
AT stefanfrischbutter stat3gainoffunctionisnotresponsibleforlowtotaligelevelsinpatientswithautoimmunechronicspontaneousurticaria
AT niklasmahnke stat3gainoffunctionisnotresponsibleforlowtotaligelevelsinpatientswithautoimmunechronicspontaneousurticaria
AT niklasmahnke stat3gainoffunctionisnotresponsibleforlowtotaligelevelsinpatientswithautoimmunechronicspontaneousurticaria
AT marcusmaurer stat3gainoffunctionisnotresponsibleforlowtotaligelevelsinpatientswithautoimmunechronicspontaneousurticaria
AT marcusmaurer stat3gainoffunctionisnotresponsibleforlowtotaligelevelsinpatientswithautoimmunechronicspontaneousurticaria
AT thomasburmeister stat3gainoffunctionisnotresponsibleforlowtotaligelevelsinpatientswithautoimmunechronicspontaneousurticaria
AT karolinekrause stat3gainoffunctionisnotresponsibleforlowtotaligelevelsinpatientswithautoimmunechronicspontaneousurticaria
AT karolinekrause stat3gainoffunctionisnotresponsibleforlowtotaligelevelsinpatientswithautoimmunechronicspontaneousurticaria
AT martinmetz stat3gainoffunctionisnotresponsibleforlowtotaligelevelsinpatientswithautoimmunechronicspontaneousurticaria
AT martinmetz stat3gainoffunctionisnotresponsibleforlowtotaligelevelsinpatientswithautoimmunechronicspontaneousurticaria